Stimulating spontaneous reporting of adverse drug reactions by a patient: Directed incentive

Drug Safety

Volumn 26, Issue 10, 2003, Pages 741-742

  Jankovic, Slobodan M ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CILAZAPRIL; DOXYCYCLINE; ENALAPRIL; MAPROTILINE; PANTOPRAZOLE; PARACETAMOL; PROPRANOLOL; TICLOPIDINE;

AGGRESSION; COST BENEFIT ANALYSIS; COUGHING; DIARRHEA; DRUG SURVEILLANCE PROGRAM; HUMAN; LETTER; MEDICAL LITERATURE; MEDICAL STUDENT; PARESTHESIA; PRIORITY JOURNAL; RASH; RECTUM HEMORRHAGE; SIDE EFFECT; SYNCOPE; VISUAL IMPAIRMENT;

EID: 0041621787     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200326100-00007     Document Type: Letter

References (4)

1. Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother 1995; 29: 365-9
2. Alvarez-Requejo A, Carvajal A, Begaud B, et al. Under-reporting of adverse drug reactions: estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 1998; 54: 483-8
3. Lewis MA, Kuhl-Habich D, von Rosen J. Drug use and adverse event monitoring in German children. Int J Clin Pharmacol Ther 2001; 39: 507-12
4. Naranjo CA, Busto U, Sellers Emet al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45